Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Degree of adherence to recommended antiviral treatment during the pandemic and post-pandemic periods of influenza A(H1N1)pdm09 in 148 intensive care units in Spain.

Canadell L, Martín-Loeches I, Díaz E, Trefler S, Grau S, Yebenes JC, Almirall J, Olona M, Sureda F, Blanquer J, Rodriguez A; GETGAG.

Med Intensiva. 2015 May;39(4):222-33. doi: 10.1016/j.medin.2014.06.001. Epub 2014 Aug 5. English, Spanish.

2.

Early non-invasive ventilation treatment for severe influenza pneumonia.

Masclans JR, Pérez M, Almirall J, Lorente L, Marqués A, Socias L, Vidaur L, Rello J; H1N1 GTEI/SEMICYUC Investigators.

Clin Microbiol Infect. 2013 Mar;19(3):249-56. doi: 10.1111/j.1469-0691.2012.03797.x. Epub 2012 Mar 8.

3.

Transjugular intrahepatic portosystemic shunt for the treatment of sinusoidal obstruction syndrome in a liver transplant recipient and review of the literature.

Campos-Varela I, Castells L, Dopazo C, Pérez-Lafuente M, Allende H, Len O, Llopart L, Vargas V, Charco R.

Liver Transpl. 2012 Feb;18(2):201-5. doi: 10.1002/lt.22351. Review.

4.

Evolution of biliary complications after liver transplantation: a single European series.

Gantxegi A, Caralt M, Bilbao I, Castells L, Lázaro JL, Llopart L, Díez I, Dopazo C, Sapisochín G, Pérez M, Charco R.

Transplant Proc. 2011 Apr;43(3):745-8. doi: 10.1016/j.transproceed.2011.01.102.

PMID:
21486589
5.

Impact of early oseltamivir treatment on outcome in critically ill patients with 2009 pandemic influenza A.

Rodríguez A, Díaz E, Martín-Loeches I, Sandiumenge A, Canadell L, Díaz JJ, Figueira JC, Marques A, Alvarez-Lerma F, Vallés J, Baladín B, García-López F, Suberviola B, Zaragoza R, Trefler S, Bonastre J, Blanquer J, Rello J; H1N1 SEMICYUC Working Group.

J Antimicrob Chemother. 2011 May;66(5):1140-9. doi: 10.1093/jac/dkq511. Epub 2011 Jan 7.

PMID:
21385717
6.

Acute kidney injury in critical ill patients affected by influenza A (H1N1) virus infection.

Martin-Loeches I, Papiol E, Rodríguez A, Diaz E, Zaragoza R, Granada RM, Socias L, Bonastre J, Valverdú M, Pozo JC, Luque P, Juliá-Narvaéz JA, Cordero L, Albaya A, Serón D, Rello J; H1N1 SEMICYUC Working Group.

Crit Care. 2011 Feb 22;15(1):R66. doi: 10.1186/cc10046.

7.

Severe 2009 A/H1N1v influenza in pregnant women in Spain.

Maraví-Poma E, Martin-Loeches I, Regidor E, Laplaza C, Cambra K, Aldunate S, Guerrero JE, Loza-Vazquez A, Arnau E, Almirall J, Lorente L, Arenzana A, Magret M, Reig Valero R, Marquez E, Gonzalez N, Bermejo-Martin JF, Rello J; Grupo Español de Trabajo de Gripe Grave A (SEMICYUC).

Crit Care Med. 2011 May;39(5):945-51. doi: 10.1097/CCM.0b013e318208ee12.

PMID:
21263317
8.

Selection and viral load kinetics of an oseltamivir-resistant pandemic influenza A (H1N1) virus in an immunocompromised patient during treatment with neuraminidase inhibitors.

Antón A, López-Iglesias AA, Tórtola T, Ruiz-Camps I, Abrisqueta P, Llopart L, Marcos MÁ, Martínez MJ, Tudó G, Bosch F, Pahissa A, de Anta MT, Pumarola T.

Diagn Microbiol Infect Dis. 2010 Nov;68(3):214-9. doi: 10.1016/j.diagmicrobio.2010.08.003.

PMID:
20955912
9.

Severe pandemic (H1N1)v influenza A infection: report on the first deaths in Spain.

Martin-Loeches I, Rodriguez A, Bonastre J, Zaragoza R, Sierra R, Marques A, Juliá-Narvaez J, Diaz E, Rello J; H1N1 SEMICYUC Working Group.

Respirology. 2011 Jan;16(1):78-85. doi: 10.1111/j.1440-1843.2010.01874.x.

PMID:
20946335
10.

[Pandemic influenza A (H1N1)v in the intensive care unit: what have we learned?].

Rodríguez A, Lisboa T, Rello J; Grupo Español de Trabajo de Gripe A Grave/SEMICYUC.

Arch Bronconeumol. 2010 Mar;46 Suppl 2:24-31. doi: 10.1016/S0300-2896(10)70017-X. Spanish.

11.

Non-anatomical intestinal transplantation.

Charco R, Malagelada C, Llopart L, Bueno J, Bilbao I, Caralt M, Vilallonga R, Gavaldá J, Dot J, Abu-Suboh M, Planas M, Accarino A, Armengol-Miró JR, Azpiroz F.

Rev Esp Enferm Dig. 2009 Feb;101(2):139-41, 141-3. English, Spanish.

12.

Cytomegalovirus disease as a risk factor for graft loss and death after orthotopic liver transplantation.

de Otero J, Gavaldà J, Murio E, Vargas V, Calicó I, Llopart L, Rosselló J, Margarit C, Pahissa A.

Clin Infect Dis. 1998 Apr;26(4):865-70.

PMID:
9564465
13.

Risk factors for acute renal failure requiring dialysis after liver transplantation.

Bilbao I, Charco R, Balsells J, Lazaro JL, Hidalgo E, Llopart L, Murio E, Margarit C.

Clin Transplant. 1998 Apr;12(2):123-9.

PMID:
9575400
14.

[Nosocomial septic shock caused by Streptococcus pyogenes].

Fernández MA, Pigrau C, Baena JA, Llopart L.

Enferm Infecc Microbiol Clin. 1994 Jun-Jul;12(6):319-20. Spanish. No abstract available.

PMID:
8080874
15.

Changes in peripheral blood lymphocyte patterns during early acute liver rejection: B cell increase as an index of rejection.

Charco R, Máñez R, Caragol I, Llopart L, Español T, Margarit C.

Transplant Proc. 1992 Feb;24(1):146. No abstract available.

PMID:
1539215
16.

Isolation of Toxoplasma gondii from immunocompromised patients using tissue culture.

Calicó I, Caballero E, Martinez O, Arcalís Arce L, Llopart L, Ocaña I, Juste C.

Infection. 1991 Sep-Oct;19(5):340-2. No abstract available.

PMID:
1800373

Supplemental Content

Loading ...
Support Center